Answers are grounded in this paper and cite their sources.
In patients with NDO due to MS and SCI, 4 weeks of treatment with solifenacin 10 mg improved urodynamic variables and QoL versus placebo and was well tolerated. Neurourol. Urodynam. 36:414-421, 2017.
No takes yet. Share an insight, caveat, or question.
Amarenco et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: